| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.04 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.09 | 0.04 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.04 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.04 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |